Combined with the research of Fim H and PapG inhibitors, we speculate that the mechanism of VSP in the treatment of UTIs may lie in inhibiting bacterial adhesion and invasion, and intervening in the process of bacterial and host infection. The gene discussed is PAPOLG; the disease is infection.